4//SEC Filing
Farid Ramy 4
Accession 0001209191-23-008166
CIK 0001888886other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 7:09 PM ET
Size
10.6 KB
Accession
0001209191-23-008166
Insider Transaction Report
Form 4
Farid Ramy
Director
Transactions
- Conversion
Ordinary Shares
2023-02-07+642,245→ 3,260,495 total(indirect: By Schrodinger, Inc.) - Purchase
American Depositary Shares
2023-02-07$15.00/sh+275,000$4,125,000→ 275,000 total(indirect: By Schrodinger, Inc.)→ Ordinary Shares (825,000 underlying) - Conversion
Series B Preferred Shares
2023-02-07−642,245→ 0 total(indirect: By Schrodinger, Inc.)→ Ordinary Shares (642,245 underlying)
Footnotes (4)
- [F1]All outstanding Preferred Shares automatically converted into Ordinary Shares immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one Ordinary Share for each one Preferred Share, based on the conversion price currently in effect. The Preferred Shares have no expiration date.
- [F2]The Reporting Person is President, Chief Executive Officer and a member of the board of directors of Schrodinger, Inc. ("Schrodinger") and may be deemed to share voting and dispositive power over the shares held by Schrodinger. The Reporting Person disclaims beneficial ownership of the shares held by Schrodinger.
- [F3]Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.
- [F4]The American Depositary Shares were purchased in the Issuer's initial public offering.
Documents
Issuer
Structure Therapeutics Inc.
CIK 0001888886
Entity typeother
Related Parties
1- filerCIK 0001797707
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 7:09 PM ET
- Size
- 10.6 KB